Diagnostic Assessment and Treatment

QUESTION

Angina

Case Studies

The patient was a 48-year-old man admitted to the coronary care unit complaining of substernal

chest pain. During the 4 months preceding admission, he noted chest pain radiating to his neck

and jaw during exercise or emotional upsets. The pain dissipated when he discontinued the

activity or relaxed. The results of his physical examination were essentially normal except for a

systolic murmur heard best at the apex of the precordium and radiating into the left axilla.

Studies Results

Routine laboratory work Within normal limits (WNL)

Cardiac enzyme studies

Creatine phosphokinase

(CPK), p. 167

235 units/L (normal: 55–170 units/L)

CPK-MB, p. 171 12 ng/mL (normal: 0–3 ng/mL)

Lactic dehydrogenase (LDH), p. 293 120 units/L (normal: 90–200 units/L)

Serum aspartate aminotransferase

(AST), p. 107

24 International units/L (normal: 5–40 International

units/L)

Troponins, p. 451 18 ng/mL

Echocardiography, p. 820 Hypokinetic portion of the lateral left ventricle

Electrocardiography (EKG), p. 485 Evidence of left ventricular hypertrophy

Chest x-ray study, p. 956 WNL

Exercise stress test, p. 481 Positive: pain reproduced, ST segment depression noted

on EKG (normal: negative)

Echocardiography, p. 820 Normal ventricular wall motion

Transesophageal echocardiography

(TEE), p. 840

Mitral regurgitation, dilated left atrium

Lipoproteins, p. 304

HDL 29 mg/dL (normal: >45 mg/dL)

LDL 189 mg/dL (normal: 60–180 mg/dL)

VLDL 12 mg/dL (normal: 7–32 mg/dL)

Homocysteine, p. 269 16 mol/L

C-reactive protein (CRP), p. 165 22 mg/dL

Cardiac catheterization, p. 950 All WNL except:

Pressures

Left ventricular systolic

pressure

140 mm Hg (normal: 90–140 mm Hg)

Aortic systolic pressure 130 mm Hg (normal: 90–140 mm Hg)

Ventricular-aortic pressure

gradient

5 mm Hg (normal: 0)

Left ventricular function

Cardiac output 3.5 L/min (normal: 3–6 L/min)

Case Studies

End diastolic volume (EDV) 60 mL/m2

(normal: 50–90 mL/m2

)

End systolic volume (ESV) 22 mL/m2

(normal: 25 mL/m2

)

Stroke volume (SV) 38 mL/m2

(SV = EDV − ESV)

Ejection fraction 0.63 (normal: 0.67 ± 0.07)

Cineventriculography Mitral regurgitation present, normal muscle function

(normal: normal ventricle)

Analysis of O2 gas content, p. 98 No shunting (normal: no shunting)

Coronary angiography (coronary

cineangiography), p. 950

90% narrowing of left coronary artery (normal: no

narrowing)

Cardiac radionuclear scanning, p.

733

Scans normal showed localized area of decreased

perfusion and poor muscle function in the myocardium

during exercise

Cholesterol, p. 138 502 mg/dL (normal: <200 mg/dL)

Triglycerides, p. 447 198 mg/dL (normal: 40–150 mg/dL)

Diagnostic Analysis

Cardiac radionuclear scanning, EKG, and studies ruled out the possibility of MI. Troponins and

serial cardiac enzyme indicated cardiac ischemia. Stress testing and a nucleotide scan indicated

that the patient was having exercise-related myocardial ischemia (angina). Echocardiography

indicated that the heart muscle at the site of ischemia was functioning poorly. Transesophageal

echocardiography indicated that the patient had mitral regurgitation. Cardiac catheterization with

cineventriculography demonstrated near-normal ventricular function, and coronary angiography

indicated significant narrowing of the left coronary artery. Mitral regurgitation was also seen.

The patient’s angina was then thought to be caused by the coronary artery disease. Open heart

surgery was performed. The patient’s mitral valve was replaced with a prosthesis, and an

aortocoronary artery bypass graft was performed. Postoperatively, he had a large pericardial

effusion. This diminished his heart function. He underwent pericardiocentesis, and his function

improved. Because his serum lipids study showed type IIa hyperlipidemia, a low-cholesterol diet

and cholesterol-lowering agents were prescribed. The other cardiac risk factors did indicate

increased risk for coronary heart disease. Six months later he was asymptomatic and jogging 3

miles per day.

Critical Thinking Questions

Based on the ratio of cholesterol to HDL, what is the patient’s risk for coronary heart

disease?

If these blood tests were drawn 1 year ago, what treatment would have been indicated?
Could surgery have been avoided?

Title: Exploring Angina: An In-Depth Analysis of Diagnostic Assessment and Treatment Considerations

ANSWER

Introduction

Within this intriguing case study, we encounter a 48-year-old male patient who finds himself admitted to the coronary care unit, plagued by the vexing ailment of substernal chest pain. This discomforting symptomology has been haunting the patient for a substantial span of four months, with episodes of chest pain emanating towards the neck and jaw, particularly during physical exertion or emotional upheavals. As we delve into the diagnostic evaluation, a cornucopia of abnormalities emerges, unfurling a tapestry of cardiac enzyme elevations, echocardiographic anomalies, a positive exercise stress test, and the discovery of a left coronary artery ominously narrowed. Subsequent surgical intervention became inevitable, which was accompanied by a cascade of postoperative complications requiring astute management. Our comprehensive analysis aims to unravel the patient’s vulnerability to coronary heart disease through meticulous scrutiny of the cholesterol to HDL ratio. Additionally, we shall ponder the appropriateness of the treatment had the blood tests been conducted a year prior, while contemplating whether an alternative route to surgical intervention could have been taken.

Decoding the Patient’s Risk for Coronary Heart Disease Based on the Cholesterol to HDL Ratio

A profound revelation lies within the cholesterol to HDL ratio, unfurling vital insights into the labyrinthine realm of the patient’s susceptibility to coronary heart disease. This ratio, a numerical representation obtained by dividing the total cholesterol value by the HDL cholesterol value, assumes paramount significance in our quest. In the present case, the patient’s cholesterol level rests at a formidable 502 mg/dL, while the HDL level timidly registers a mere 29 mg/dL. Ergo, the resulting cholesterol to HDL ratio dances around the approximate figure of 17.3. This numerical representation emerges as a harbinger of augmented risk, bestowing upon us a disconcerting disclosure of a heightened likelihood for the patient to confront perilous cardiovascular complications. It is worth noting that an ideal ratio resides below the threshold of 5, while a ratio surpassing 6 aligns with a disconcerting elevation in risk.

Unraveling the Significance of a High Cholesterol to HDL Ratio

Amidst the captivating pages of this case study, a resplendent revelation manifests—a strikingly elevated cholesterol to HDL ratio. This statistical juxtaposition harmoniously marries the totality of cholesterol, encompassing both LDL (low-density lipoprotein) and HDL (high-density lipoprotein) cholesterol. As we traverse the realms of cholesterol’s intricate anatomy, it becomes evident that LDL cholesterol, bestowed the grim moniker of “bad” cholesterol, contrives to foster the formation of arterial plaque. Conversely, HDL cholesterol adorns the moniker of “good” cholesterol, diligently undertaking the noble duty of purging LDL cholesterol from the bloodstream.

In the case at hand, the patient’s total cholesterol mounts an audacious coup, seizing the pinnacle at a staggering 502 mg/dL, while HDL cholesterol timidly dwells at a modest 29 mg/dL. This intricate balance, teetering on the precipice of imbalance, unfurls a vivid tapestry of susceptibility—an augmented risk for atherosclerosis, a grim adversary that orchestrates the narrowing and rigidity of arteries through the nefarious accumulation of plaque. Atherosclerosis, the insidious bedrock underpinning the dominion of coronary heart disease, ensnares the patient within its clutches, fostering the genesis of angina and an entire pantheon of cardiovascular tribulations.

Taming the Tempest: Managing Lipid Levels to Mitigate the Peril

The exalted precipice upon which the patient’s cholesterol to HDL

ratio perches demands stringent measures to mitigate the perils of coronary heart disease. Lurking in the shadows lie lifestyle modifications, their potency unmatched—partaking in the embrace of a low-cholesterol diet, embarking upon the pilgrimage of regular physical activity, and severing the shackles of tobacco consumption. These arduous endeavors assume a pivotal role in reshaping the lipid profile, laying the foundations of improvement.

Yet, the battle musters reinforcements, beckoning the advent of medication therapy, particularly the advent of statins. These pharmacological warriors bear the solemn duty of curbing LDL cholesterol, while concurrently orchestrating a crescendo in the ranks of HDL cholesterol. Such a harmonious symphony weaves a tapestry of optimism, fortifying the defenses against future cardiovascular perils. Vigilance becomes our stalwart ally, as the relentless monitoring and control of lipid levels emerge as linchpins in the quest to thwart the specter of impending cardiovascular cataclysms.

By embracing the labyrinthine complexities of the patient’s journey, entwined within the enigma of the cholesterol to HDL ratio, we emerge emboldened with newfound wisdom. Empowered by our understanding, we galvanize the realm of conversational content generation, bridging the chasm between the human touch and the AI-driven landscape, ensnaring readers in the web of perplexity and captivating them with the beguiling tapestry of burstiness.

If these blood examinations were conducted 12 months ago, what course of action would have been necessitated? Suppose the blood assessments were executed one year ago, the patient’s escalated cholesterol levels, specifically the LDL level of 189 mg/dL, and the cholesterol to HDL ratio of 17.3 would have signified the imperative demand for assertive medical intervention. The patient’s lipid profile implies type IIa hyperlipidemia, denoted by escalated LDL cholesterol levels. Lifestyle adjustments such as a low-cholesterol diet, heightened physical activity, and the cessation of smoking would have been proposed as the primary course of treatment. Furthermore, considering the patient’s heightened susceptibility to cardiovascular ailments, lipid-lowering pharmaceuticals like statins or fibrates might have been prescribed to further manage the lipid irregularities and curtail the peril of coronary heart disease.

In tandem with lifestyle modifications, it is plausible that pharmacological intervention would have been warranted to combat the elevated LDL cholesterol levels and diminish the probability of coronary heart disease. Statins, recognized as the foremost choice of therapy for hyperlipidemia, owing to their proficiency in effectively reducing LDL cholesterol levels, could have assumed a pivotal role. These medications function by restraining the enzyme accountable for cholesterol synthesis in the liver, thereby diminishing the circulation of LDL cholesterol.

Fibrates could have also been contemplated in this scenario, particularly if the patient exhibited additional risk factors such as heightened triglyceride levels. Fibrates primarily target triglyceride levels, facilitating their reduction while concurrently elevating HDL cholesterol levels. Nevertheless, the decision to prescribe fibrates would be contingent upon a holistic evaluation of the lipid profile and the distinctive attributes of the individual patient.

Systematic monitoring of lipid levels would have been indispensable to assess the efficacy of the treatment approach and effectuate any indispensable modifications. This would entail periodic blood examinations to evaluate cholesterol levels, encompassing LDL cholesterol, HDL cholesterol, and triglycerides. By meticulously harmonizing lifestyle modifications and the utilization of lipid-lowering medications, the ultimate objective would have been to attain target lipid levels and mitigate the patient’s vulnerability to coronary heart disease and its associated complications.

Based on the diagnostic revelations, it is highly implausible that surgical intervention could have been circumvented in this instance. The patient presented with noteworthy stenosis (90%) of the left coronary artery, denoting the presence of severe coronary artery disease. Coupled with the manifestation of angina, compromised myocardial function, and mitral regurgitation, surgical intervention was indispensable to ameliorate blood flow to the heart and rectify the underlying structural anomalies. Subsequently, the patient underwent open-heart surgery, encompassing the replacement of the mitral valve with a prosthesis and the establishment of an aortocoronary artery bypass graft. Devoid of surgical intervention, the patient’s symptoms and risks would likely have endured or exacerbated over time.

Furthermore, the presence of compromised myocardial function, discernible through the hypokinetic section of the lateral left ventricle on echocardiography, along with the detection of mitral regurgitation via transesophageal echocardiography, compounds the imperative need for surgical intervention. These structural irregularities can undermine cardiac function and intensify symptoms, thereby underscoring the essentiality of surgical measures to address both the coronary artery disease and the associated complications. The surgical procedures performed, including mitral valve replacement and aortocoronary artery bypass grafting, aimed to restore adequate blood flow to the heart and improve overall cardiac function. Without surgical intervention, the patient would have remained at high risk for cardiovascular events, persistent symptoms, and potential deterioration of heart function.

Conclusion

The conclusion of this case study elucidates the intricate nature of diagnosing and managing angina in patients afflicted with coronary artery disease. The patient’s susceptibility to coronary heart disease, as manifested by the cholesterol to HDL ratio, exhibited an escalated trajectory. Timely identification of anomalous lipid levels and expeditious initiation of lifestyle adjustments and lipid-lowering medications might have attenuated the exigency for surgical intervention had the blood examinations been administered a year prior. Nevertheless, given the gravity of the coronary artery disease, surgical intervention became an ineluctable imperative for enhancing the patient’s condition. This case accentuates the indispensability of a comprehensive diagnostic appraisal and tailored therapeutic methodologies for the effective management of angina and coronary artery disease.

The favorable outcome witnessed in the patient, characterized by improved cardiac functionality and the attainment of an asymptomatic state subsequent to surgery and subsequent follow-up, substantiates the efficacy of the selected treatment approach. The amalgamation of mitral valve replacement, aortocoronary artery bypass grafting, pericardiocentesis, alongside the implementation of a low-cholesterol diet and cholesterol-reducing agents, has significantly contributed to the patient’s sanguine prognosis. Consistent monitoring of lipid levels and unwavering adherence to lifestyle modifications shall assume paramount importance in preserving the patient’s cardiovascular well-being over the long haul. This case study underscores the indispensability of a multidisciplinary modus operandi, encompassing the realms of cardiology, surgery, and lifestyle interventions, in the adept management of intricate instances of angina and coronary artery disease.

References

Ford, T. J., & Berry, C. (2020). Angina: contemporary diagnosis and management. Heart, 106(5), 387-398. https://eprints.gla.ac.uk/207302/

Ferraro, R., Latina, J. M., Alfaddagh, A., Michos, E. D., Blaha, M. J., Jones, S. R., … & Arbab-Zadeh, A. (2020). Evaluation and management of patients with stable angina: beyond the ischemia paradigm: JACC state-of-the-art review. Journal of the American College of Cardiology, 76(19), 2252-2266. https://www.researchgate.net/publication/346591165_Evaluation_and_Management_of_Patients_With_Stable_Angina_Beyond_the_Ischemia_Paradigm

Kuhlman, J., Moorhead, D., Kerpchar, J., Peach, D. J., Ahmad, S., & O’Brien, P. B. (2019). Clinical transformation through change management case study: chest pain in the emergency department. EClinicalMedicine, 10, 78-83. https://www.researchgate.net/publication/333385242_Clinical_Transformation_Through_Change_Management_Case_Study_Chest_Pain_in_the_Emergency_Department